Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Breban

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Medecine Et Maladies Infectieuses|November 3, 2018
Veillonella parvula spondylodiscitisH Gouze, L Noussair, I Padovano, et al.
Arthritis and Rheumatism|November 11, 1999
Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritisM Breban, M Dougados, F Picard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic ratsM Breban, J L Fernández-Sueiro, J A Richardson, et al.
European Cytokine Network|April 3, 2001
Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human beta2 microglobulin transgenic ratsH S Blanchard, E Dernis-Labous, D Lamarque, et al.
Annals of the Rheumatic Diseases|May 14, 2008
Coexistence of spondyloarthropathy and multiple sclerosis: a series of 21 casesD Wendling, R-M Flipo, M Breban, et al.
Annals of the Rheumatic Diseases|October 14, 2015
Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective studyJ Montoya, N B Matta, P Suchon, et al.
Rheumatology (Oxford, England)|November 8, 2002
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label studyM Breban, E Vignon, P Claudepierre, et al.
European Cytokine Network|July 29, 1998
Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulinV Bertrand, S Quéré, R Guimbaud, et al.
Rheumatology (Oxford, England)|January 27, 2006
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-upL Gossec, A Le Henanff, M Breban, et al.
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group]D Farge, M Breban, L Guillevin, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Medecine Et Maladies Infectieuses|November 3, 2018
Veillonella parvula spondylodiscitisH Gouze, L Noussair, I Padovano, et al.
Arthritis and Rheumatism|November 11, 1999
Intensified-dose (4 gm/m2) cyclophosphamide and granulocyte colony-stimulating factor administration for hematopoietic stem cell mobilization in refractory rheumatoid arthritisM Breban, M Dougados, F Picard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1996
T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic ratsM Breban, J L Fernández-Sueiro, J A Richardson, et al.
European Cytokine Network|April 3, 2001
Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human beta2 microglobulin transgenic ratsH S Blanchard, E Dernis-Labous, D Lamarque, et al.
Annals of the Rheumatic Diseases|May 14, 2008
Coexistence of spondyloarthropathy and multiple sclerosis: a series of 21 casesD Wendling, R-M Flipo, M Breban, et al.
Annals of the Rheumatic Diseases|October 14, 2015
Patients with ankylosing spondylitis have been breast fed less often than healthy controls: a case-control retrospective studyJ Montoya, N B Matta, P Suchon, et al.
Rheumatology (Oxford, England)|November 8, 2002
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label studyM Breban, E Vignon, P Claudepierre, et al.
European Cytokine Network|July 29, 1998
Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulinV Bertrand, S Quéré, R Guimbaud, et al.
Rheumatology (Oxford, England)|January 27, 2006
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-upL Gossec, A Le Henanff, M Breban, et al.
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Bone marrow transplantation in the treatment of autoimmune diseases. ISAMAIR Group]D Farge, M Breban, L Guillevin, et al.
Pageof 6